Danieli B. Salinas

Fundació Privada Clínic per a La Recerca Biomèdica

Also affiliated with Hospital Clínico de la Universidad Católica, Vertex Pharmaceuticals (United States)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial”.

Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial

The Lancet Respiratory Medicine(2025)10.1016/s2213-2600(24)00407-7

N/A

1.4DataRank · unranked

50 citations

Ajay S. Kasi, Jessica E. Pittman, Renée Jensen, L. Thia, Philip Robinson +44 more

High rates of anxiety detected in mothers of children with inconclusive cystic fibrosis screening results

Journal of Cystic Fibrosis(2022)10.1016/j.jcf.2022.12.002

N/A

0DataRank · unranked

26 citations

Danieli B. Salinas, Taylor M. Cosanella, Choo Phei Wee, Muhammed M. Saeed, Thomas G. Keens +2 more

Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in People with Cystic Fibrosis from the U.S. Patient Registry

Annals of the American Thoracic Society(2022)10.1513/annalsats.202201-024oc

N/A

0DataRank · unranked

9 citations

Choo Phei Wee, Barbara Bailey, Karen S. Raraigh, Douglas Conrad, Danieli B. Salinas